Interpace Biosciences, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2020
Total Assets: $45.7M
Liabilities Breakdown FY2020
Total Liabilities: $28.2M
Asset Breakdown
Total Assets: $45.7M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $2.8M | 6.1% |
| Accounts Receivable | $8.0M | 17.6% |
| Inventory | $2.1M | 4.5% |
| Property, Plant & Equipment | $7.3M | 16.1% |
| Goodwill | $8.4M | 18.5% |
| Intangible Assets | $11.4M | 24.8% |
| Other Assets | $5.7M | 12.5% |
Liabilities Breakdown
Total Liabilities: $28.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $4.5M | 16.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $23.7M | 84.0% |